Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases

被引:86
作者
Odiit, M
Coleman, PG
Liu, WC
McDermott, JJ
Fèvre, EM
Welburn, SC
Woolhouse, MEJ
机构
[1] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England
[2] Uganda AIDS Control Project, Kampala, Uganda
[3] Univ Edinburgh, Ctr Trop Vet Med, Edinburgh EH25 9RG, Midlothian, Scotland
[4] Int Livestock Res Inst, Nairobi, Kenya
关键词
rhodesiense sleeping sickness; under-detection; Uganda; disease burden;
D O I
10.1111/j.1365-3156.2005.01470.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To formally quantify the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness (SS) during an epidemic in Uganda, a decision tree (under-detection) model was developed; concurrently, to quantify the subset of undetected cases that sought health care but were not diagnosed, a deterministic (subset) model was developed. The values of the under-detection model parameters were estimated from previously published records of the duration of symptoms prior to presentation and the ratio of early to late stage cases in 760 SS patients presenting at LIRI hospital, Tororo, Uganda during the 1988-1990 epidemic of SS. For the observed early to late stage ratio of 0.47, we estimate that the proportion of under-detection in the catchment area of LIRI hospital was 0.39 (95% CI 0.37-0.41) i.e. 39% of cases are not reported. Based on this value, it is calculated that for every one reported death of SS, 12.0 (95% CI 11.0-13.0) deaths went undetected in the LIRI hospital catchment area - i.e. 92% of deaths are not reported. The deterministic (subset) model structured on the possible routes of a SS infection to either diagnosis or death through the health system or out of it, showed that of a total of 73 undetected deaths, 62 (CI 60-64) (85%) entered the healthcare system but were not diagnosed, and 11 (CI 11-12) died without seeking health care from a recognized health unit. The measure of early to late stage presentation provides a tractable measure to determine the level of rhodesiense SS under-detection and to gauge the effects of interventions aimed at increasing treatment coverage.
引用
收藏
页码:840 / 849
页数:10
相关论文
共 25 条
[1]  
ABARU DE, 1985, TROP MED PARASITOL, V36, P72
[2]  
Burrows R, 1999, J CLIN LIGAND ASSAY, V22, P251
[3]   LABORATORY DIAGNOSIS OF TRYPANOSOMIASIS [J].
CATTAND, P ;
DERAADT, P .
CLINICS IN LABORATORY MEDICINE, 1991, 11 (04) :899-908
[4]  
Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304
[5]   The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda [J].
Fèvre, EM ;
Coleman, PG ;
Odiit, M ;
Magona, JW ;
Welburn, SC ;
Woolhouse, MEJ .
LANCET, 2001, 358 (9282) :625-628
[6]  
Legros D, 1999, B SOC PATHOL EXOT, V92, P171
[7]   Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda [J].
Legros, D ;
Evans, S ;
Maiso, F ;
Enyaru, JCK ;
Mbulamberi, D .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1999, 93 (04) :439-442
[8]  
MATOVU FS, 1982, E AFR MED J, V59, P390
[9]  
MBULAMBERI DB, 1989, ANN SOC BELG MED TR, V69, P173
[10]  
MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429